Sermorelin Sleep Protocol
82
التعاون
2
300
beginner
May 17, 2026
نظرة عامة
The Sermorelin Sleep Protocol leverages the natural relationship between growth hormone secretion and sleep architecture to enhance both simultaneously. Approximately 70% of daily GH secretion occurs during slow-wave (deep) sleep, and conversely, adequate GH signaling promotes deeper and more restorative sleep stages. Sermorelin is a 29-amino-acid GHRH analog that is identical to the first 29 amino acids of endogenous GHRH. It has a long clinical history, having been FDA-approved in the 1990s for pediatric GH deficiency, and has a long history of legal pharmacy compounding; it is not on the FDA Category 2 restricted-compounding list. When administered 30 minutes before bed on an empty stomach, Sermorelin amplifies the natural nocturnal GH surge that occurs approximately 60-90 minutes after sleep onset. This enhanced GH pulse deepens slow-wave sleep, which in turn promotes further GH release — creating a positive feedback loop. Low-dose Ipamorelin (100mcg) is added to amplify this pulse via ghrelin-receptor co-activation without doses high enough to cause any sleep-disrupting appetite signaling. The protocol is classified as beginner-friendly because Sermorelin has decades of clinical safety data, the doses are conservative, and the timing aligns with natural physiology rather than fighting it. Users typically report improvements in sleep quality within the first week, with deeper, less interrupted sleep and more vivid dreaming (indicating enhanced REM cycling). Over 4-8 weeks, the cumulative effect of improved nightly GH secretion manifests as better recovery, improved skin texture, modest fat reduction, and increased morning energy. This is an excellent entry point for individuals new to peptide therapy who want meaningful benefits with minimal complexity.
بروتوكول الجرعة
200 mcg
كل جرعة
100 mcg
كل جرعة
الأهداف والدليل
تحذيرات
- Sermorelin is not on the FDA Category 2 restricted list and has a long history of legal pharmacy compounding. Ipamorelin remains FDA Category 2 (restricted) as of July 2026. Administer 30 min before bed on empty stomach.
Comments
Sign in to join the discussion
تحذير: هذا الكود مقدم من قبل المجتمع ويهدف لغرض البحث فقط. لا يتحقق Peptide Contacts من سلامة أو فعالية الأكواد المقدمة. استشر محترف صحي مؤهل قبل استخدام أي بروتوكول بروتيني.